Ardena completes divestment of its Södertälje drug substance site in Sweden to Nanologica
4 February 2026
No Comments
Ghent, Belgium, 29th January 2026 – Ardena, a specialist CDMO and bioanalytical CRO enabling
Tag: Nanologica
